Sequence requirements of the hammerhead RNA self-cleavage reaction
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
A previously well-characterized hammerhead catalytic RNA consisting of a 24-nucleotide substrate and a 19-nucleotide ribozyme was used to perform an extensive mutagenesis study. The cleavage rates of 21 different substrate mutations and 24 different ribozyme mutations were determined. Only one of the three phylogenetically conserved base pairs but all nine of the conserved single-stranded residues in the central core are needed for self cleavage. In most cases the mutations did not alter the ability of the hammerhead to assemble into a bimolecular complex. In the few cases where mutant hammerheads did not assemble, it appeared to be the result of the mutation stabilizing an alternate substrate or ribozyme secondary structure. All combinations of mutant substrate and mutant ribozyme were less active than the corresponding single mutations, suggesting that the hammerhead contains few, if any, replaceable tertiary interactions as are found in tRNA. The refined consensus hammerhead resulting from this work was used to identify potential hammerheads present in a variety of Escherichia coli gene sequences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, only 11 of the 33 nucleotides that the polymerase was required to synthesize are critical for hammerhead function (31, 32).”
From An RNA polymerase ribozyme that synthesizes its own ancestor (2020) · cites this paper as [31]
Citations
Cites
Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates
Milligan, J. F., Groebe, D. R., Witherell, G. W., & Uhlenbeck, O. C. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.21.8783 · Cited by 2,136
Self-citationMapping adenines, guanines, and pyrimidines in RNA
Donis-Keller, H., Maxam, A. M., & Gilbert, W. (1977) · Nucleic Acids Research · doi:10.1093/nar/4.8.2527 · Cited by 1,371
Simple RNA enzymes with new and highly specific endoribonuclease activities
Haseloff, J., & Gerlach, W. L. (1988) · Nature · doi:10.1038/334585a0 · Cited by 1,103
Information content of binding sites on nucleotide sequences
Schneider, T. D., Stormo, G. D., Gold, L., & Ehrenfeucht, A. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90165-8 · Cited by 945
Self-citationDirect chemical method for sequencing RNA.
Peattie, D. A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.4.1760 · Cited by 940
A small catalytic oligoribonucleotide
Uhlenbeck, O. C. (1987) · Nature · doi:10.1038/328596a0 · Cited by 930
Self-citationSelf-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites
Forster, A. C., & Symons, R. H. (1987) · Cell · doi:10.1016/0092-8674(87)90562-9 · Cited by 666
New rapid gel sequencing method for RNA
SIMONCSITS, A., BROWNLEE, G. G., BROWN, R. S., RUBIN, J. R., & GUILLEY, H. (1977) · Nature · doi:10.1038/269833a0 · Cited by 332
Self-cleavage of virusoid RNA is performed by the proposed 55-nucleotide active site
Forster, A. C., & Symons, R. H. (1987) · Cell · doi:10.1016/0092-8674(87)90657-x · Cited by 317
Zaug, A. J., Grosshans, C. A., & Cech, T. R. (1988) · Biochemistry · doi:10.1021/bi00425a008 · Cited by 249
Cited by
Items 301–400 of 468
[49] Ribozymes in treatment of inherited retinal disease
Shaw, L. C., Whalen, P. O., Drenser, K. A., Yan, W., Hauswirth, W. W., & Lewin, A. S. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)16761-8 · Cited by 14
Vanario‐Alonso, C. E., O’Hara, E., McGinnis, W. J., & Pick, L. (1995) · Mechanisms of Development · doi:10.1016/0925-4773(95)00448-3 · Cited by 14
Function and biological applications of catalytic nucleic acids
Gaughan, D. J., & Whitehead, A. S. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00021-4 · Cited by 14
Chapter 30. Catalytic RNA (Ribozymes) as Drugs
Usman, N., & McSwiggen, J. A. (1995) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60943-4 · Cited by 16
Chemical Engineering of RNase Resistant and Catalytically Active Hammerhead Ribozymes
Burlina, F., Favre, A., & Fourrey, J. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00144-2 · Cited by 14
Chemically Cross-Linked Hammerhead Ribozyme as an Efficient RNA Interference Tool
Wang, L., Wu, C., Zhang, Q., Wang, Y., Liu, Y., Yang, W., Ye, S.-L., Tian, Y., & Xu, L. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c12702 · Cited by 13
An aptazyme-based molecular device that converts a small-molecule input into an RNA output
Ayukawa, S., Sakai, Y., & Kiga, D. (2012) · Chemical Communications · doi:10.1039/c2cc31886e · Cited by 13
Ribozyme- and siRNA-Mediated Suppression of RGS-Containing RhoGEF Proteins
Wang, Q., Liu, M., Kozasa, T., Rothestein, J. D., Sternweis, P. C., & Neubig, R. R. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)89015-3 · Cited by 13
Warashina, M., Kuwabara, T., Nakamatsu, Y., Takagi, Y., Kato, Y., & Taira, K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049634m · Cited by 13
Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers
Mir, A. A. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.1906 · Cited by 13
Hammerhead ribozyme cleavage of hamster prion pre-mRNA in complex cell-free model systems
Denman, R. B., Purow, B. W., Rubenstein, R., & Miller, D. L. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90870-q · Cited by 13
Development of Ribozymes For Gene Therapy.
Sullivan, S. M. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12399210 · Cited by 12
Fu, D.-J., Rajur, S. B., & McLaughlin, L. W. (1994) · Biochemistry · doi:10.1021/bi00250a045 · Cited by 13
Yau, E. H., Butler, M. C., & Sullivan, J. M. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.05.020 · Cited by 13
Towards Higher Complexity in the RNA World: Hairpin Ribozyme Supported RNA Recombination
Hieronymus, R., & Müller, S. (2021) · ChemSystemsChem · doi:10.1002/syst.202100003 · Cited by 13
Lee, T., Wong, K. Y., Giambaşu, G. M., & York, D. M. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-381286-5.00002-0 · Cited by 12
Cogoi, S., Suraci, C., Terra, E. D., Diviacco, S., MAREL, G. V. D., BOOM, J. H. V., Quadrifoglio, F., & Xodo, L. E. (2000) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729000421466 · Cited by 12
Serra, P., Bertolini, E., Martínez, M. C., Cambra, M., & Flores, R. (2017) · Scientific Reports · doi:10.1038/srep42825 · Cited by 12
Buskiewicz, I. A., & Burke, J. M. (2012) · RNA · doi:10.1261/rna.030999.111 · Cited by 12
Eckstein, F., & Bramlage, B. (1999) · Biopolymers · doi:10.1002/1097-0282(1999)52:3<147::aid-bip40>3.0.co;2-i · Cited by 17
Inhibition of type I procollagen production by tRNAVal CTE‐HSP47 ribozyme
Hagiwara, S., Nakamura, K., Hamada, H., Sasaki, K., Ito, Y., Kuribayashi, K., Sato, T., Sato, Y., Takahashi, M., Kogawa, K., et al. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.404 · Cited by 12
Matulić‐Adamić, J., Gonzalez, C., Usman, N., & Beigelman, L. N. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00030-3 · Cited by 12
A Multi-Model Approach to Nucleic Acid-Based Drug Development
Gautherot, I., & Sodoyer, R. (2004) · BioDrugs · doi:10.2165/00063030-200418010-00004 · Cited by 12
Gu, J., Nadler, J. L., & Rossi, J. J. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6353-2_5 · Cited by 12
Growth Inhibition by A Triple Ribozyme Targeted to Repetitive B2 Transcripts
Crone, T. M., Schalles, S. L., Benedict, C. M., Pan, W., Ren, L., Loy, S. E., Isom, H. C., & Clawson, G. A. (1999) · Hepatology · doi:10.1002/hep.510290449 · Cited by 12
Zhang, S., Stancek, M., & Isaksson, L. A. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4301 · Cited by 11
The size of hammerhead ribozymes is related to cleavage kinetics: the role of substrate length
Hormes, R., & Sczakiel, G. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01461-x · Cited by 11
Singh, R., Pandey, H. P., & Singh, R. H. (2003) · PubMed · Cited by 11
Goila, R., & Banerjea, A. C. (2004) · Oligonucleotides · doi:10.1089/oli.2004.14.249 · Cited by 11
Setlik, R. F., Shibata, M., Sarma, R. H., Sarma, M. H., Kazim, A. L., Ornstein, R. L., Tomasi, T. B., & Rein, R. (1995) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1995.10508861 · Cited by 11
HIV-1 TAR as Anchoring Site for Optimized Catalytic RNAs
Puerta‐Fernández, E., Jesus, A. B.-D., Romero‐López, C., & Berzal‐Herranz, A. (2003) · Biological Chemistry · doi:10.1515/bc.2003.040 · Cited by 11
1-Methylguanosine substitutions of the conserved guanosine residues inactive the hammerhead ribozyme
Limauro, S. E., Benseler, F., & McLaughlin, L. W. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)80069-4 · Cited by 11
Castanotto, D., Li, H., Chow, W. A., Rossi, J. J., & Deshler, J. O. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.1 · Cited by 11
Structural determinants of RNA function
Wimberly, B. T., Varani, G., & Tinoco, I. (1991) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(91)90039-v · Cited by 11
Wang, L., & Ruffner, D. E. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4355 · Cited by 11
Self-citationCorrect folding of a ribozyme induced by nonspecific macromolecules
Nashimoto, M. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01294.x · Cited by 10
Liao, A. M., Pan, W., Benson, J. C., Wong, A. D., Rose, B. J., & Caltagirone, G. T. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00523 · Cited by 10
Kuo, T.-C., & Herrin, D. L. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4197 · Cited by 10
Zakharchuk, A. N., Doronin, K., Karpov, V. G., Krougliak, V. A., & Naroditsky, B. S. (1995) · Gene · doi:10.1016/0378-1119(95)00251-z · Cited by 10
Ribozyme-Mediated Decrease in Mumps Virus Nucleocapsid mRNA Level and Progeny in Infected Vero Cells
Albuquerque-Silva, J., Milican, F., Bollen, A., & Houard, S. A. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.279 · Cited by 10
Kisseleva, N., Khvorova, A., Westhof, É., Schiemann, O., & Wolfson, A. D. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0129 · Cited by 10
Ribozyme‐Mediated Cancer Gene Therapy
Irie, A., Bouffard, D. Y., & Scanlon, K. J. (1997) · International Journal of Urology · doi:10.1111/j.1442-2042.1997.tb00203.x · Cited by 10
Assembly of long l -RNA by native RNA ligation
Yu, C., Kabza, A. M., & Sczepanski, J. T. (2021) · Chemical Communications · doi:10.1039/d1cc04296c · Cited by 9
CTAB‐mediated enrichment for active forms of novel dimeric maxizymes
Nakayama, A., Kuwabara, T., Warashina, M., & Taira, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00325-7 · Cited by 9
Takashi, S. (1994) · Gene · doi:10.1016/0378-1119(94)90410-3 · Cited by 9
Catalytic Activity of an RNA Domain Derived from the U6-U4 RNA Complex
Yang, J.-H., Cedergren, R., & Nadal‐Ginard, B. (1994) · Science · doi:10.1126/science.8272868 · Cited by 9
Three-Dimensional Structure of the Hammerhead Ribozyme
McKay, D. (1996) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-61202-2_9 · Cited by 9
Ogawa, A., Fujikawa, M., Tanimoto, R., Matsuno, K., Uehara, R., Inoue, H., & Takahashi, H. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00840 · Cited by 8
The Small Ribozymes: Common and Diverse Features Observed Through the FRET Lens
Walter, N. G., & Perumal, S. (2008) · Springer series in biophysics · doi:10.1007/978-3-540-70840-7_5 · Cited by 9
Inhibition of HIV-1 Replication and Dimerization Interference by Dual Inhibitory RNAs
Sanchez-Luque, F. J., Reyes-Darias, J. A., Puerta‐Fernández, E., & Berzal‐Herranz, A. (2010) · Molecules · doi:10.3390/molecules15074757 · Cited by 11
Computational design and experimental verification of pseudoknotted ribozymes
Najeh, S., Zandi, K., Kharma, N., & Perreault, J. (2023) · RNA · doi:10.1261/rna.079148.122 · Cited by 8
Detection of hammerhead ribozyme-mediated cleavage and reduced expression of LacZ′ mRNA in E. coli
Junn, E., & Kang, C. (1996) · Genetic Analysis Biomolecular Engineering · doi:10.1016/1050-3862(96)00138-6 · Cited by 8
Regulation of Ribozyme Activity with Short Oligonucleotides
Komatsu, Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.457 · Cited by 8
Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer
Tong, A. W., Zhang, Y., Cunningham, C. C., Maples, P. B., & Nemunaitis, J. J. (2001) · Clinical Lung Cancer · doi:10.3816/clc.2001.n.007 · Cited by 8
Sarma, R. H., Sarma, M. H., Rein, R., Shibata, M., Setlik, R. S., Ornstein, R. L., Kazim, A. L., Cairo, A. M., & Tomasi, T. B. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01388-h · Cited by 8
Ojha, R. P., Dhingra, M. M., Sarma, M. H., Myer, Y. P., Setlik, R. F., Shibata, M., Kazim, A. L., Ornstein, R. L., Rein, R., Turner, C. J., et al. (1997) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1997.10508186 · Cited by 8
Domi, A., Beaud, G., & Favre, A. (1996) · Biochimie · doi:10.1016/s0300-9084(96)80011-3 · Cited by 8
Wichert, A., Holm, P. S., Dietel, M., & Lage, H. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700045 · Cited by 8
Ribozyme Structure and Function
Warashina, M., Zhou, D., Kuwabara, T., & Taira, K. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00152-1 · Cited by 8
Gu, J., Nadler, J. L., & Rossi, J. J. (1997) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006855219018 · Cited by 8
Hammerhead Ribozymes Against Virus and Viroid RNAs
Carbonell, A., Flores, R., & Gago‐Zachert, S. (2012) · RNA technologies · doi:10.1007/978-3-642-27426-8_16 · Cited by 7
Alcorn, J. L., Merritt, T. M., Farach‐Carson, M. C., Wang, H. H., & Hecht, J. T. (2009) · RNA · doi:10.1261/rna.1335909 · Cited by 7
Chadha, K. C., Dembinski, W., DUNN, C., ARADI, J., BARDOS, T., DUNN, J., & AMBRUSSR, J. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.08.002 · Cited by 7
Strategies to Identify Potential Therapeutic Target Sites in RNA
Lützelberger, M., & Kjems, J. (2006) · Springer eBooks · doi:10.1007/3-540-27262-3_12 · Cited by 7
A hammerhead ribozyme substrate and reporter for in vitro kinetoplastid RNA editing
Wang, B., Salavati, R., Heidmann, S. K., & Stuart, K. D. (2002) · RNA · doi:10.1017/s135583820202962x · Cited by 7
Nakamura, S., Honkura, R., Ugaki, M., Ohshima, M., & Ohashi, Y. (1995) · 日本植物病理學會報 · doi:10.3186/jjphytopath.61.53 · Cited by 7
Alternative Approaches for the Application of Ribozymes as Gene Therapies for Retroviral Infections
Campbell, T., & Sullengert, B. A. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60668-7 · Cited by 7
Sugimoto, N., Sasaki, M., & Tanaka, A. (1993) · Supramolecular chemistry · doi:10.1080/10610279308038303 · Cited by 7
Allosterically Controlled Single-Chained Maxizymes with Extremely High and Specific Activity
Kuwabara, T., Hamada, M., Warashina, M., & Taira, K. (2001) · Biomacromolecules · doi:10.1021/bm010054g · Cited by 7
Zhang, Q., Ohannesian, D. W., & Erickson, L. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061507 · Cited by 7
Design of Hammerhead Ribozymes to Distinguish Single Base Changes in Substrate RNA
Singh, K. K., Schluff, P., Lehnert, L., & Krupp, G. (1996) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1996.6.165 · Cited by 7
Two RNA Folds from One Sequence: A Ribozyme with Versatile Substrate Processing Abilities
Zhu, J., Dierks, D., Möller, C., Balke, D., & Müller, S. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202409047 · Cited by 6
Enzymatic combinatorial nucleoside deletion scanning mutagenesis of functional RNA
Wawrzyniak-Turek, K., & Höbartner, C. (2014) · Chemical Communications · doi:10.1039/c4cc04719b · Cited by 6
Re-characterization of hammerhead ribozymes as molecular tools for intermolecular RNA cleavage
Liu, G., Huang, X., Pu, Q., Zhao, Y., Du, F., Dong, J., Cui, X., & Tang, Z. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00995j · Cited by 6
Nagata, T., Sakurai, Y., Hara, Y., Mashima, T., Kodaki, T., & Katahira, M. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08538.x · Cited by 6
Inhibition of Plasmodium falciparum ispH ( lytB ) Gene Expression by Hammerhead Ribozyme
Vinayak, S., & Sharma, Y. D. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0075 · Cited by 6
Variables and Strategies in Development of Therapeutic Post-Transcriptional Gene Silencing Agents
Sullivan, J. M., Yau, E. H., Kolniak, T. A., Sheflin, L. G., Taggart, R. T., & Abdelmaksoud, H. E. (2011) · Journal of Ophthalmology · doi:10.1155/2011/531380 · Cited by 7
RNA-Mediated Therapeutics: From Gene Inactivation to Clinical Application
Kalavrizioti, D., Vourekas, A., Stamatopoulou, V., Toumpeki, C., Giannouli, S., Stathopoulos, C., & Drainas, D. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778194253 · Cited by 12
Probing the Cleavage Activity of the Hammerhead Ribozyme Using Analog Complexes
Kuimelis, R. G., & McLaughlin, L. W. (1996) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-61202-2_11 · Cited by 6
Lilley, D. M. J. (1999) · Springer eBooks · doi:10.1007/978-94-011-4631-9_10 · Cited by 6
Erratum: correction: Retrotransposition of a bacterial group II intron
Cousineau, B., Lawrence, S., Smith, D., & Belfort, M. (2001) · Nature · doi:10.1038/35102087 · Cited by 7
Importance of purine-pyridine hydroxyl and purine amino groups for hammerhead ribozyme cleavage
Tanaka, H., Endo, T., Hosaka, H., Takai, K., Yokoyama, S., & Takaku, H. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)80828-3 · Cited by 6
Mitrasinovic, O. M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2189 · Cited by 6
Lustig, B., Lin, N., Smith, S. M., Jernigan, R. L., & Jeang, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.17.3531 · Cited by 6
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAs
Myers, J. M., & Sullivan, J. M. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102431 · Cited by 6
Discovery of natural non-circular permutations in non-coding RNAs
Eckert, I., Friedrich, R., Weinberg, C. E., & Weinberg, Z. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad137 · Cited by 6
Hammerhead Ribozymes as Therapeutic Agents for Bladder Cancer
Irie, A., Kashani–Sabet, M., Kj, S., Uchida, Τ., & Baba, S. (2000) · Molecular Urology · doi:10.1089/10915360050138602 · Cited by 5
Role of the Nucleolus in HIV Infection and Therapy
Arizala, J. A. C., & Rossi, J. J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0514-6_17 · Cited by 6
Use of Nucleoside Analogues to Probe Biochemical Processes
McLaughlin, L. W., Wilson, M., & Ha, S. B. (1999) · Elsevier eBooks · doi:10.1016/b978-0-08-091283-7.00062-x · Cited by 5
Lilley, D. M. J. (1999) · Genetica · doi:10.1023/a:1003733012815 · Cited by 5
Elucidating Evolutionary Mechanisms and Variants of the Hammerhead Ribozyme Using In Vitro Selection
Brill, J., Nurmi, C., & Li, Y. (2024) · ChemBioChem · doi:10.1002/cbic.202400432 · Cited by 4
Blanchet, M.-F., St-Onge, K., Lisi, V., Robitaille, J., Hamel, S., & Major, F. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku816 · Cited by 4
Suppressor tRNA-based Biosensors for Detecting Analytes
Ogawa, A. (2020) · Analytical Sciences · doi:10.2116/analsci.20scr01 · Cited by 4
Ribozymes in Cancer Gene Therapy
Beger, C., KRÜGER, M., & Wong‐Staal, F. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50006-9 · Cited by 4
Coupling between substrate binding and allosteric regulation in ribozyme catalysis
Araki, M., Hashima, M., Okuno, Y., & Sugiura, Y. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00336-9 · Cited by 4
Kuriyama, M., Kondo, Y., & Tanaka, Y. (2014) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.887098 · Cited by 4
Roychowdhury-Saha, M., Roychowdhury, S., & Burke, D. H. (2011) · RNA Biology · doi:10.4161/rna.8.5.16036 · Cited by 4
Zhang, Q., Ohannesian, D. W., Kreklau, E. L., & Erickson, L. C. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29361-7 · Cited by 4
Viroids: The Smallest Known Infectious Agents Cause Accumulation of Viroid-Specific Small RNAs
Matoušek, J., Riesner, D., & Steger, G. (2012) · RNA technologies · doi:10.1007/978-3-642-27426-8_26 · Cited by 4
Translational suppression by hammerhead ribozymes and inactive variants in S. cerevisiae
Yim, S.-H., Park, I., Ahn, J. K., & Kang, C. (2000) · Biomolecular Engineering · doi:10.1016/s1389-0344(99)00052-0 · Cited by 4
Metadata
- Authors
- Ruffner, D. E., Stormo, G. D., & Uhlenbeck, O. C.
- Affiliations
- University of Colorado Boulder (US)
- ORCID
- Stormo, Gary D.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1990-11-01
- Volume
- 29
- Issue
- 47
- Pages
- 10695-10702
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2002048308
- Cited by
- 470
- References
- 27
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 4 · 2022: 1 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 3 · 2017: 8 · 2016: 2 · 2015: 2 · 2014: 6 · 2013: 5 · 2012: 6
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r01gm041776-01)
- National Institute of General Medical Sciences (GM 28755, R01GM028755, GM-36944, GM41776)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- hammerhead ribozyme, RNA self-cleavage, ribozymes, mutagenesis, tertiary interactions, secondary structure, consensus sequence
- MeSH terms
- Base Sequence, Escherichia coli, Molecular Sequence Data, Nucleic Acid Conformation, RNA, Bacterial, Structure-Activity Relationship, Mutagenesis, Site-Directed, RNA, Catalytic, Consensus Sequence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.